Rare diseases
Investigational molecules
Locations
Study on Pembrolizumab for Patients with High-Risk Stage III Melanoma After Surgery
AustriaStudy of Atezolizumab and Tiragolumab Compared to Durvalumab for Patients with Advanced Non-Small Cell Lung Cancer After Chemoradiation
AustriaStudy on Esketamine and Propofol for Anesthesia in Electroconvulsive Therapy for Patients with Major Depression
AustriaStudy on the Effectiveness and Safety of AC102 Injection vs. Oral Prednisolone for Patients with Sudden Hearing Loss
AustriaStudy on Trastuzumab Deruxtecan for Patients with Advanced Non-Small Cell Lung Cancer with HER2 Mutations
AustriaStudy Comparing Adagrasib and Docetaxel for Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation
AustriaStudy on Caplacizumab and Immunosuppressive Therapy for Adults with Immune-Mediated Thrombotic Thrombocytopenic Purpura
AustriaStudy on the Safety and Effectiveness of Crinecerfont for Adults with Classic Congenital Adrenal Hyperplasia
AustriaStudy on the Long-Term Safety of Seladelpar for Patients with Primary Biliary Cholangitis
AustriaStudy on Durvalumab, Tremelimumab, and Enfortumab Vedotin for Patients with Muscle Invasive Bladder Cancer Ineligible or Refusing Cisplatin
AustriaStudy on Golcadomide and R-CHOP Drug Combination for Patients with Untreated High-risk Large B-cell Lymphoma
AustriaStudy of ribociclib combined with hormone therapy for patients with early-stage hormone receptor-positive, HER2-negative breast cancer
AustriaTell us about your condition – we search every trial in Europe and connect you with the right site.
